Overall (N = 190) | |
---|---|
Sex, n (%) | |
Female | 105 (55) |
Male | 85 (45) |
Age, median (Q1, Q3), years | 33 (26, 43) |
ECOG performance statusa, n (%) | |
0 | 106 (56) |
1 | 76 (40) |
2 | 6 (3) |
Previous treatment | |
Resection/surgery | 132 (70) |
Bisphosphonates | 38 (20) |
Radiotherapy | 37 (20) |
Chemotherapy | 21 (11) |
GCTB disease type, n (%) | |
Recurrent unresectable | 92 (48) |
Primary unresectable | 43 (23) |
Recurrent resectable | 29 (15) |
Primary resectable | 26 (14) |
Location of target lesionb, n (%) | |
Pelvis/sacrum | 61 (32) |
Lower extremities | 39 (21) |
Lung | 38 (20) |
Spine | 18 (10) |
Upper extremities | 17 (9) |
Otherc | 11 (6) |
Skull/neck | 5 (3) |
Missing | 1 (1) |